117 related articles for article (PubMed ID: 27442426)
1. 3-Methylcholanthrene/Aryl-Hydrocarbon Receptor-Mediated Hypertension Through eNOS Inactivation.
Chang CC; Hsu YH; Chou HC; Lee YG; Juan SH
J Cell Physiol; 2017 May; 232(5):1020-1029. PubMed ID: 27442426
[TBL] [Abstract][Full Text] [Related]
2. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27.
Hsu YH; Chang CC; Yang NJ; Lee YH; Juan SH
J Cell Physiol; 2014 Oct; 229(10):1455-65. PubMed ID: 24535918
[TBL] [Abstract][Full Text] [Related]
3. 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex.
Chang CC; Sue YM; Yang NJ; Lee YH; Juan SH
PLoS One; 2014; 9(3):e92793. PubMed ID: 24658119
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells.
Hung MJ; Cherng WJ; Hung MY; Wu HT; Pang JH
J Hypertens; 2010 May; 28(5):940-51. PubMed ID: 20375905
[TBL] [Abstract][Full Text] [Related]
5. Mediating effects of aryl-hydrocarbon receptor and RhoA in altering brain vascular integrity: the therapeutic potential of statins.
Chang CC; Lee PS; Chou Y; Hwang LL; Juan SH
Am J Pathol; 2012 Jul; 181(1):211-21. PubMed ID: 22720799
[TBL] [Abstract][Full Text] [Related]
6. 3'-Oxo-tabernaelegantine A (OTNA) selectively relaxes pulmonary arteries by inhibiting AhR.
Long P; Li Y; Wen Q; Huang M; Li S; Lin Y; Huang X; Chen M; Ouyang J; Ao Y; Qi Q; Zhang H; Ye W; Cheng G; Zhang X; Zhang D
Phytomedicine; 2021 Nov; 92():153751. PubMed ID: 34563984
[TBL] [Abstract][Full Text] [Related]
7. The essential role of transient receptor potential vanilloid 1 in simvastatin-induced activation of endothelial nitric oxide synthase and angiogenesis.
Su KH; Lin SJ; Wei J; Lee KI; Zhao JF; Shyue SK; Lee TS
Acta Physiol (Oxf); 2014 Nov; 212(3):191-204. PubMed ID: 25183024
[TBL] [Abstract][Full Text] [Related]
8. Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
Xing SS; Yang XY; Zheng T; Li WJ; Wu D; Chi JY; Bian F; Bai XL; Wu GJ; Zhang YZ; Zhang CT; Zhang YH; Li YS; Jin S
Vascul Pharmacol; 2015 Sep; 72():141-52. PubMed ID: 26187353
[TBL] [Abstract][Full Text] [Related]
9. Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein.
Procopio C; Andreozzi F; Laratta E; Cassese A; Beguinot F; Arturi F; Hribal ML; Perticone F; Sesti G
Endocrinology; 2009 Aug; 150(8):3584-93. PubMed ID: 19359389
[TBL] [Abstract][Full Text] [Related]
10. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
Viswambharan H; Ming XF; Zhu S; Hubsch A; Lerch P; Vergères G; Rusconi S; Yang Z
Circ Res; 2004 Apr; 94(7):918-25. PubMed ID: 14988229
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells.
Zhao Z; Hu J; Gao X; Liang H; Yu H; Liu S; Liu Z
Oncotarget; 2017 May; 8(18):30030-30038. PubMed ID: 28415790
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells.
Juan SH; Lee JL; Ho PY; Lee YH; Lee WS
Eur J Pharmacol; 2006 Jan; 530(1-2):1-8. PubMed ID: 16359657
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation.
Cheng WH; Ho WY; Chang CF; Lu PJ; Cheng PW; Yeh TC; Hong LZ; Sun GC; Hsiao M; Tseng CJ
Br J Pharmacol; 2013 Oct; 170(4):847-58. PubMed ID: 23889671
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1.
Ching LC; Kou YR; Shyue SK; Su KH; Wei J; Cheng LC; Yu YB; Pan CC; Lee TS
Cardiovasc Res; 2011 Aug; 91(3):492-501. PubMed ID: 21493704
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase.
Hien TT; Kim ND; Pokharel YR; Oh SJ; Lee MY; Kang KW
Toxicol Appl Pharmacol; 2010 Aug; 246(3):171-83. PubMed ID: 20546771
[TBL] [Abstract][Full Text] [Related]
16. High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase.
Chang FJ; Yuan HY; Hu XX; Ou ZJ; Fu L; Lin ZB; Wang ZP; Wang SM; Zhou L; Xu YQ; Wang CP; Xu Z; Zhang X; Zhang CX; Ou JS
J Mol Cell Cardiol; 2014 Sep; 74():209-19. PubMed ID: 24887036
[TBL] [Abstract][Full Text] [Related]
17. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
Ning WH; Zhao K
Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990
[TBL] [Abstract][Full Text] [Related]
18. Effects of bezafibrate on the expression of endothelial nitric oxide synthase gene and its mechanisms in cultured bovine endothelial cells.
Wang Y; Wang Y; Yang Q; Yan JT; Zhao C; Cianflone K; Wang DW
Atherosclerosis; 2006 Aug; 187(2):265-73. PubMed ID: 16256120
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV Improves Vasodilatation Function by Regulating the PI3K/Akt/eNOS Signaling Pathway in Rat Aorta Endothelial Cells.
Lin XP; Cui HJ; Yang AL; Luo JK; Tang T
J Vasc Res; 2018; 55(3):169-176. PubMed ID: 29972829
[TBL] [Abstract][Full Text] [Related]
20. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
Watts VL; Motley ED
Exp Biol Med (Maywood); 2009 Feb; 234(2):132-9. PubMed ID: 19064940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
